» Articles » PMID: 21798880

Beneficial Effects of Right Ventricular Non-apical Vs. Apical Pacing: a Systematic Review and Meta-analysis of Randomized-controlled Trials

Overview
Journal Europace
Date 2011 Jul 30
PMID 21798880
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Previous studies have suggested that right ventricular apical (RVA) pacing may have deleterious effects on left ventricular function. Whether right ventricular non-apical (RVNA) pacing offers a better alternative to RVA pacing is unclear. We aimed to conduct a systematic review and meta-analysis of randomized-controlled trials (RCTs) in order to compare the mid- and long-term effects of RVA and RVNA pacing.

Methods And Results: We systematically searched the Cochrane library, EMBASE, and MEDLINE databases for RCTs comparing RVA with RVNA pacing over >2 months follow-up. Data were pooled using random-effects models. Fourteen RCTs met our inclusion criteria involving 754 patients. Compared with subjects randomized to RVA pacing, those randomized to RVNA pacing had greater left ventricular ejection fractions (LVEF) at the end of follow-up [13 RCTs: weighted mean difference (WMD) 4.27%, 95% confidence interval (CI) 1.15%, 7.40%]. RVNA had a better LVEF at the end of follow-up in RCTs with follow-up ≥12 months (WMD 7.53%, 95% CI 2.79%, 12.27%), those with <12 months of follow-up (WMD 1.95%, 95% CI 0.17%, 3.72%), and those conducted in patients with baseline LVEF ≤40-45% (WMD 3.71%, 95% CI 0.72%, 6.70%); no significant difference was observed in RCTs of patients whose baseline LVEF was preserved. Randomized-controlled trials provided inconclusive results with respect to exercise capacity, functional class, quality of life, and survival.

Conclusions: While RCTs suggest that LVEF is higher with RVNA than with RVA pacing, there remains a need for large RCTs to compare the safety and efficacy of RVNA and RVA pacing.

Citing Articles

Conduction System Pacing for CRT: A Physiological Alternative.

Herweg B, Mumtaz M, Vijayaraman P Arrhythm Electrophysiol Rev. 2025; 14:e04.

PMID: 40017670 PMC: 11865673. DOI: 10.15420/aer.2024.10.


Atrioventricular Block Treatment: Pacing Site, AV Synchrony, or Both?.

Biffi M, Bagatin A, Spadotto A, Lazzeri M, Carecci A, Bartoli L J Clin Med. 2025; 14(3).

PMID: 39941650 PMC: 11818370. DOI: 10.3390/jcm14030980.


[Complications of permanent cardiac pacing: a retrospective observational study of 462 cases from the University Hospital Center Hedi Chaker of Sfax, Tunisia].

Kallel R, Hammami R, Dammak A, Safi F, Akrout M, Abid L Pan Afr Med J. 2024; 49():24.

PMID: 39720395 PMC: 11667084. DOI: 10.11604/pamj.2024.49.24.25891.


Clinical Decision Making and Technical Approaches in Implantable Cardioverter-Defibrillator Procedures: A Step by Step Critical Appraisal of Literature.

Roseboom E, Smit M, Groenveld H, Rienstra M, Maass A Rev Cardiovasc Med. 2024; 25(11):403.

PMID: 39618862 PMC: 11607494. DOI: 10.31083/j.rcm2511403.


Dual-chamber pacing confers better myocardial performance and improves clinical outcomes compared to single-chamber pacing.

Mohan B, Batta A World J Cardiol. 2024; 16(11):626-631.

PMID: 39600992 PMC: 11586728. DOI: 10.4330/wjc.v16.i11.626.